Pre-eclampsia risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Common risk factors in the development of preeclampsia include: | Common [[risk factors]]] in the development of preeclampsia include: [[nulliparity]], multifetal gestations, [[preeclampsia]] in a previous [[pregnancy]], [[chronic hypertension]] , pregestational [[diabetes]] ,[[gestational diabetes]], [[thrombophilia]], [[systemic lupus erythematosus]], [[body mass index]] greater than 30 at the beginning of prenatal care [[antiphospholipid antibody syndrome]], maternal age 35 years or older, [[kidney]] disease, Assisted reproductive technology, [[obstructive sleep apnea]], African-American decent. | ||
[[ | |||
, | |||
,[[ | |||
,[[ | |||
, | |||
,[[ | |||
,[[ | |||
,[[ | |||
,[[ | |||
, | |||
,[[ | |||
,Assisted reproductive technology | |||
,[[ | |||
,African-American decent | |||
== Risk factors == | == Risk factors == | ||
*Common risk factors in the development of [[preeclampsia]] include:<ref>{{cite journal|title=Gestational Hypertension and Preeclampsia|journal=Obstetrics & Gynecology|volume=135|issue=6|year=2020|pages=e237–e260|issn=0029-7844|doi=10.1097/AOG.0000000000003891}}</ref> | *Common risk factors in the development of [[preeclampsia]] include:<ref>{{cite journal|title=Gestational Hypertension and Preeclampsia|journal=Obstetrics & Gynecology|volume=135|issue=6|year=2020|pages=e237–e260|issn=0029-7844|doi=10.1097/AOG.0000000000003891}}</ref> | ||
*[[ Nulliparity]] | * [[Nulliparity]] | ||
* Multifetal [[gestations]] | * Multifetal [[gestations]] | ||
* [[Preeclampsia]] in a previous [[pregnancy]] | * [[Preeclampsia]] in a previous [[pregnancy]] | ||
| Line 31: | Line 16: | ||
* [[Thrombophilia]] | * [[Thrombophilia]] | ||
* [[Systemic lupus erythematosus]] | * [[Systemic lupus erythematosus]] | ||
* [[Body mass index]] greater than 30 at the | * [[Body mass index]] greater than 30 at the beginning of prenatal care | ||
* [[Antiphospholipid antibody syndrome]] | * [[Antiphospholipid antibody syndrome]] | ||
* Maternal age 35 years or older | * Maternal age 35 years or older | ||
| Line 37: | Line 22: | ||
* Assisted reproductive technology | * Assisted reproductive technology | ||
* [[Obstructive sleep apnea]] | * [[Obstructive sleep apnea]] | ||
* African-American | * African-American descent | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Latest revision as of 02:43, 28 January 2021
|
Pre-eclampsia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pre-eclampsia risk factors On the Web |
|
American Roentgen Ray Society Images of Pre-eclampsia risk factors |
|
Risk calculators and risk factors for Pre-eclampsia risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2]
Overview
Common risk factors] in the development of preeclampsia include: nulliparity, multifetal gestations, preeclampsia in a previous pregnancy, chronic hypertension , pregestational diabetes ,gestational diabetes, thrombophilia, systemic lupus erythematosus, body mass index greater than 30 at the beginning of prenatal care antiphospholipid antibody syndrome, maternal age 35 years or older, kidney disease, Assisted reproductive technology, obstructive sleep apnea, African-American decent.
Risk factors
- Common risk factors in the development of preeclampsia include:[1]
- Nulliparity
- Multifetal gestations
- Preeclampsia in a previous pregnancy
- Chronic hypertension
- Pregestational diabetes
- Gestational diabetes
- Thrombophilia
- Systemic lupus erythematosus
- Body mass index greater than 30 at the beginning of prenatal care
- Antiphospholipid antibody syndrome
- Maternal age 35 years or older
- Kidney disease
- Assisted reproductive technology
- Obstructive sleep apnea
- African-American descent
References
- ↑ "Gestational Hypertension and Preeclampsia". Obstetrics & Gynecology. 135 (6): e237–e260. 2020. doi:10.1097/AOG.0000000000003891. ISSN 0029-7844.